newsfilter
← Latest News
GlobeNewswire·

Codexis Reports Fourth Quarter and Fiscal Year 2024 Financial Results

Total revenue of $59.3 million for the fiscal year ended December 31, 2024 Expect double digit growth for total revenue in 2025 2025 to demonstrate acceleration of commercial growth through double-stranded RNA